본문바로가기
Q
U
I
C
K

PR

SK bioscience company news updates

Media Zoom

S.Korea approves first domestically developed COVID vaccine

2022.06.29

 

 

SEOUL, June 29 (Reuters) - South Korea approved its first domestically developed COVID-19 vaccine, manufactured by SK bioscience Co Ltd (302440.KS), for general public use following positive clinical data, authorities said on Wednesday.

 

The SKYCovione vaccine was authorised for a two-dose regimen on people aged 18 or older, with shots given four weeks apart, according to the Ministry of Food and Drug Safety.